Broadfin Capital’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $3.57M | Buy |
1,888,039
+268,039
| +17% | +$507K | 0.48% | 31 |
|
2019
Q3 | $1.75M | Buy |
+1,620,000
| New | +$1.75M | 0.32% | 36 |
|
2019
Q2 | – | Sell |
-2,030,925
| Closed | -$12.2M | – | 35 |
|
2019
Q1 | $12.2M | Buy |
2,030,925
+153,423
| +8% | +$919K | 2.51% | 13 |
|
2018
Q4 | $13.9M | Buy |
+1,877,502
| New | +$13.9M | 1.82% | 12 |
|